非处方糖尿病护士专家对糖尿病健康中护士处方的看法

Hazel I A Philips, Wellington Hutt Valley Dhb, J. Wilkinson
{"title":"非处方糖尿病护士专家对糖尿病健康中护士处方的看法","authors":"Hazel I A Philips, Wellington Hutt Valley Dhb, J. Wilkinson","doi":"10.36951/NGPXNZ.2015.001","DOIUrl":null,"url":null,"abstract":"IntroductionDiabetes mellitus (DM) is one of the most common chronic diseases throughout the world. Its management is complex and requires a lifetime of behaviour modification (Courtenay & Carey, 2008; Kara, van der Bijl, Shortridge-Baggett, Asti, & Erguney, 2006). The World Health Organisation (WHO) has predicted that there will be 366 million people with diabetes by 2030 (Kara et al., 2006). Price-Waterhouse-Coopers estimate the financial implications of diabetes will reach NZ$1000 million by 2021 (Joshy & Simmons, 2006). There will be a profound impact on the New Zealand health service as the number of people with diabetes increases along with life expectancy. Diabetes nurse specialist (DNS) prescribing has the potentialto increase accessibility and services to people with diabetes, help alleviate some of the pressure on the health service, and provide a more holistic model of care (Latter, Maben, Myall, Young, & Baileff, 2012; Wilkinson, Carryer, & Adams, 2013).Nursing practice has evolved considerably over the last 20 years with nurses extending their roles, taking on new roles, and specialising in particular areas (Bodington, 2011). Nurses who specialise in diabetes can be professionally recognised by means of a voluntary accredition process available through the New Zealand Nurses Organisation (NZNO) (Aotearoa College of Diabetes Nurses, 2014). Accreditation is defined by the National Diabetes Nurses Knowledge and Skills Framework (KSF) (New Zealand Society for the Study of Diabetes, 2009) and is aligned with the Nursing Council of New Zealand (NCNZ) requirements for professional development and recognition programmes. There are four levels in the KSF, with the most advanced being 'specialist diabetes nurse' (level 4). These nurses have developed expert diabetes practice and provide care for people with diabetes who have complex health needs. Specialist nurses have undertaken post graduate study towards or completion of a Masters degree.In addition to supporting people with diabetes to make lifestyle changes, many nurses who specialise in diabetes make changes to the dose or frequency of insulin or oral hypoglycaemic medications using standing orders (Medicines (Standing orders) Amendment Regulations, 2011). Any prescriptions for new or repeat medicines however must be provided by an authorised prescriber. Until recently, nurse practitioners have been the only nurses able to prescribe medicines in New Zealand.The primary legislation governing the supply, manufacture and prescription of medicines in New Zealand is the Medicines Amendment Act 2013. This Act enables prescribing for two classes of prescriber: authorised prescribers (medical practitioners, nurse practitioners, dentists, optometrists and midwives); and designated prescribers (nurses working in diabetes health, pharmacists and dietitians). Designated prescribers a re able to prescribe from a limited formulary within their area of practice. Specific regulations were passed in 2011 allowing DNS's to prescribe from a schedule of 26 diabetes-related medicines (Medicines (Designated Prescriber-Registered Nurses Practising in Diabetes Health) Regulations, 2011). The schedule of medicines includes lipid-lowering agents and antihypertensive medications.A project to trial DNS prescribing took place in 2011 with twelve DNS located in four demonstration sites around New Zealand authorised to prescribe underthe new regulations. The evaluation of the trial found DNS prescribing to be safe, of high quality and appropriate (Wilkinson et al., 2013). A staged roll-out to other DNS has since taken place (Budge & Snell, 2013). The 2011 project evaluation included the views of various groups of professionals who were affected by DNS prescribing, including the non-prescribing nurses who worked with the DNS who were participating in the trial.As a new initiative that would extend beyond the demonstration sites it was important to gauge the level of interest amongst the nurses most likely to become the next prescribers. …","PeriodicalId":77298,"journal":{"name":"Nursing praxis in New Zealand inc","volume":"36 1","pages":"5-17"},"PeriodicalIF":0.0000,"publicationDate":"2015-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"4","resultStr":"{\"title\":\"Non-Prescribing Diabetes Nurse Specialist Views of Nurse Prescribing in Diabetes Health\",\"authors\":\"Hazel I A Philips, Wellington Hutt Valley Dhb, J. Wilkinson\",\"doi\":\"10.36951/NGPXNZ.2015.001\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"IntroductionDiabetes mellitus (DM) is one of the most common chronic diseases throughout the world. Its management is complex and requires a lifetime of behaviour modification (Courtenay & Carey, 2008; Kara, van der Bijl, Shortridge-Baggett, Asti, & Erguney, 2006). The World Health Organisation (WHO) has predicted that there will be 366 million people with diabetes by 2030 (Kara et al., 2006). Price-Waterhouse-Coopers estimate the financial implications of diabetes will reach NZ$1000 million by 2021 (Joshy & Simmons, 2006). There will be a profound impact on the New Zealand health service as the number of people with diabetes increases along with life expectancy. Diabetes nurse specialist (DNS) prescribing has the potentialto increase accessibility and services to people with diabetes, help alleviate some of the pressure on the health service, and provide a more holistic model of care (Latter, Maben, Myall, Young, & Baileff, 2012; Wilkinson, Carryer, & Adams, 2013).Nursing practice has evolved considerably over the last 20 years with nurses extending their roles, taking on new roles, and specialising in particular areas (Bodington, 2011). Nurses who specialise in diabetes can be professionally recognised by means of a voluntary accredition process available through the New Zealand Nurses Organisation (NZNO) (Aotearoa College of Diabetes Nurses, 2014). Accreditation is defined by the National Diabetes Nurses Knowledge and Skills Framework (KSF) (New Zealand Society for the Study of Diabetes, 2009) and is aligned with the Nursing Council of New Zealand (NCNZ) requirements for professional development and recognition programmes. There are four levels in the KSF, with the most advanced being 'specialist diabetes nurse' (level 4). These nurses have developed expert diabetes practice and provide care for people with diabetes who have complex health needs. Specialist nurses have undertaken post graduate study towards or completion of a Masters degree.In addition to supporting people with diabetes to make lifestyle changes, many nurses who specialise in diabetes make changes to the dose or frequency of insulin or oral hypoglycaemic medications using standing orders (Medicines (Standing orders) Amendment Regulations, 2011). Any prescriptions for new or repeat medicines however must be provided by an authorised prescriber. Until recently, nurse practitioners have been the only nurses able to prescribe medicines in New Zealand.The primary legislation governing the supply, manufacture and prescription of medicines in New Zealand is the Medicines Amendment Act 2013. This Act enables prescribing for two classes of prescriber: authorised prescribers (medical practitioners, nurse practitioners, dentists, optometrists and midwives); and designated prescribers (nurses working in diabetes health, pharmacists and dietitians). Designated prescribers a re able to prescribe from a limited formulary within their area of practice. Specific regulations were passed in 2011 allowing DNS's to prescribe from a schedule of 26 diabetes-related medicines (Medicines (Designated Prescriber-Registered Nurses Practising in Diabetes Health) Regulations, 2011). The schedule of medicines includes lipid-lowering agents and antihypertensive medications.A project to trial DNS prescribing took place in 2011 with twelve DNS located in four demonstration sites around New Zealand authorised to prescribe underthe new regulations. The evaluation of the trial found DNS prescribing to be safe, of high quality and appropriate (Wilkinson et al., 2013). A staged roll-out to other DNS has since taken place (Budge & Snell, 2013). The 2011 project evaluation included the views of various groups of professionals who were affected by DNS prescribing, including the non-prescribing nurses who worked with the DNS who were participating in the trial.As a new initiative that would extend beyond the demonstration sites it was important to gauge the level of interest amongst the nurses most likely to become the next prescribers. …\",\"PeriodicalId\":77298,\"journal\":{\"name\":\"Nursing praxis in New Zealand inc\",\"volume\":\"36 1\",\"pages\":\"5-17\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2015-03-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"4\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Nursing praxis in New Zealand inc\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.36951/NGPXNZ.2015.001\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Nursing praxis in New Zealand inc","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.36951/NGPXNZ.2015.001","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 4

摘要

糖尿病(DM)是世界上最常见的慢性疾病之一。它的管理是复杂的,需要一生的行为修正(Courtenay & Carey, 2008;Kara, van der Bijl, Shortridge-Baggett, Asti, & Erguney, 2006)。世界卫生组织(WHO)预测,到2030年将有3.66亿人患有糖尿病(Kara et al., 2006)。普华永道估计,到2021年,糖尿病的财务影响将达到10亿新西兰元(Joshy & Simmons, 2006)。糖尿病患者的数量随着预期寿命的增加而增加,这将对新西兰的卫生服务产生深远的影响。糖尿病专科护士(DNS)处方有可能增加糖尿病患者的可及性和服务,有助于减轻医疗服务的一些压力,并提供更全面的护理模式(后,Maben, Myall, Young, & Baileff, 2012;Wilkinson, carrier, & Adams, 2013)。在过去的20年里,护理实践已经有了很大的发展,护士扩展了他们的角色,承担了新的角色,并专注于特定领域(博丁顿,2011)。专门从事糖尿病护理的护士可以通过新西兰护士组织(新西兰护士组织)(Aotearoa糖尿病护士学院,2014年)的自愿认证程序获得专业认可。认证由国家糖尿病护士知识和技能框架(KSF)(新西兰糖尿病研究协会,2009年)定义,并与新西兰护理委员会(NCNZ)对专业发展和认可计划的要求保持一致。KSF有四个级别,最高级的是“糖尿病专科护士”(第4级)。这些护士发展了糖尿病专家实践,并为有复杂健康需求的糖尿病患者提供护理。专科护士接受研究生学习或完成硕士学位。除了支持糖尿病患者改变生活方式外,许多专门从事糖尿病的护士还根据常规医嘱(2011年药品(常规医嘱)修订条例)改变胰岛素或口服降糖药的剂量或频率。但是,任何新药或重复用药的处方必须由授权的处方医师提供。直到最近,执业护士一直是新西兰唯一能够开药的护士。管理新西兰药品供应、生产和处方的主要立法是《2013年药品修正法》。该法允许两类开处方者开处方:授权开处方者(医生、护士、牙医、验光师和助产士);以及指定的处方医师(从事糖尿病健康工作的护士、药剂师和营养师)。指定开处方者可以在其执业范围内从有限的处方中开处方。2011年通过了具体法规,允许DNS从26种糖尿病相关药物的清单中开出处方(2011年《药品(指定处方医师-从事糖尿病健康的注册护士)条例》)。药物的时间表包括降脂剂和抗高血压药物。2011年进行了DNS处方试验项目,12个DNS位于新西兰四周的四个示范站点,授权根据新法规进行处方。对试验的评估发现,DNS处方是安全的、高质量的和适当的(Wilkinson et al., 2013)。此后,已分阶段推出到其他DNS (Budge & Snell, 2013)。2011年的项目评估包括受DNS处方影响的不同专业群体的观点,包括参与试验的与DNS一起工作的非处方护士。作为一项将扩展到示范站点之外的新举措,重要的是要衡量最有可能成为下一个处方者的护士的兴趣水平。…
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Non-Prescribing Diabetes Nurse Specialist Views of Nurse Prescribing in Diabetes Health
IntroductionDiabetes mellitus (DM) is one of the most common chronic diseases throughout the world. Its management is complex and requires a lifetime of behaviour modification (Courtenay & Carey, 2008; Kara, van der Bijl, Shortridge-Baggett, Asti, & Erguney, 2006). The World Health Organisation (WHO) has predicted that there will be 366 million people with diabetes by 2030 (Kara et al., 2006). Price-Waterhouse-Coopers estimate the financial implications of diabetes will reach NZ$1000 million by 2021 (Joshy & Simmons, 2006). There will be a profound impact on the New Zealand health service as the number of people with diabetes increases along with life expectancy. Diabetes nurse specialist (DNS) prescribing has the potentialto increase accessibility and services to people with diabetes, help alleviate some of the pressure on the health service, and provide a more holistic model of care (Latter, Maben, Myall, Young, & Baileff, 2012; Wilkinson, Carryer, & Adams, 2013).Nursing practice has evolved considerably over the last 20 years with nurses extending their roles, taking on new roles, and specialising in particular areas (Bodington, 2011). Nurses who specialise in diabetes can be professionally recognised by means of a voluntary accredition process available through the New Zealand Nurses Organisation (NZNO) (Aotearoa College of Diabetes Nurses, 2014). Accreditation is defined by the National Diabetes Nurses Knowledge and Skills Framework (KSF) (New Zealand Society for the Study of Diabetes, 2009) and is aligned with the Nursing Council of New Zealand (NCNZ) requirements for professional development and recognition programmes. There are four levels in the KSF, with the most advanced being 'specialist diabetes nurse' (level 4). These nurses have developed expert diabetes practice and provide care for people with diabetes who have complex health needs. Specialist nurses have undertaken post graduate study towards or completion of a Masters degree.In addition to supporting people with diabetes to make lifestyle changes, many nurses who specialise in diabetes make changes to the dose or frequency of insulin or oral hypoglycaemic medications using standing orders (Medicines (Standing orders) Amendment Regulations, 2011). Any prescriptions for new or repeat medicines however must be provided by an authorised prescriber. Until recently, nurse practitioners have been the only nurses able to prescribe medicines in New Zealand.The primary legislation governing the supply, manufacture and prescription of medicines in New Zealand is the Medicines Amendment Act 2013. This Act enables prescribing for two classes of prescriber: authorised prescribers (medical practitioners, nurse practitioners, dentists, optometrists and midwives); and designated prescribers (nurses working in diabetes health, pharmacists and dietitians). Designated prescribers a re able to prescribe from a limited formulary within their area of practice. Specific regulations were passed in 2011 allowing DNS's to prescribe from a schedule of 26 diabetes-related medicines (Medicines (Designated Prescriber-Registered Nurses Practising in Diabetes Health) Regulations, 2011). The schedule of medicines includes lipid-lowering agents and antihypertensive medications.A project to trial DNS prescribing took place in 2011 with twelve DNS located in four demonstration sites around New Zealand authorised to prescribe underthe new regulations. The evaluation of the trial found DNS prescribing to be safe, of high quality and appropriate (Wilkinson et al., 2013). A staged roll-out to other DNS has since taken place (Budge & Snell, 2013). The 2011 project evaluation included the views of various groups of professionals who were affected by DNS prescribing, including the non-prescribing nurses who worked with the DNS who were participating in the trial.As a new initiative that would extend beyond the demonstration sites it was important to gauge the level of interest amongst the nurses most likely to become the next prescribers. …
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信